Gene Query: FLG

Dataset Description Geneva Score
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 335.98
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 186.19
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 132.31
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 107.2
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 107.2
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 86.77
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 81.46
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 80.31
RNA-seq analysis to identify the genes regulated by p53-SET interplay 76.05
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 75.21
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 74.06
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 69.09
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 69.09
Splicing and epigenetic factors jointly regulate epidermal differentiation 67.77
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 67.07
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 67.07
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 64.18
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 64.18
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 63.7
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 61.64
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 60.91
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 59.09
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 58.51
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 58.29
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 57.23
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 57.23
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 55.88
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 55.16
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 54.69
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 53.02
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 52.95
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 51.93
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 49.38
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 49.12
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 44.19
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 43.5
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 42.65
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 42.65
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 42.03
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 41.98
Integrin signaling regulates YAP/TAZ to control skin homeostasis 41.79
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 41.62
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 41.62
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 40.45
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 37.7
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 37.16
G-quadruplex structures mark human regulatory chromatin 36.16
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 31.96
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 31.96
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 30.62
Expression profiling of converted and control dermal BJ fibroblasts 29.69
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 29.69
Hypoxic transcriptome of SQ20B human head and neck cancer cells 29.48
Effect of Hotair overexpression in human breast cancer cell lines 29.04
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 28.75
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 26.98
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 26.7
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 26.24
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 26.06
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 25.33
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 25.12
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 25.07
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 25.07
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 23.58
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 23.37
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 23.28
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 22.87
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 22.87
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 22.52
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 22.08
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 22.08
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 21.94
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 20.88
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 20.81
The Genomic Landscape of Atypical Fibroxanthoma 20.65
Disruption of the exocyst induces podocyte loss and dysfunction 20.62
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 20.56
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 20.54
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 19.61
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 19.58
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 19.19
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 19.19
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 19.13
Inhibition of TNBC metastasis by Gpx1 18.6
hTERT promotes cell adhesion and migration independent of telomerase activity 17.97
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 17.57
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 17.26
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 17.09
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 17.09
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 17.09
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 17.02
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 17.02
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 16.71
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 16.6
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 16.42
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 16.39
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 16.19
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 16.01
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 16.01
Epigenome regulation during epidermal lineage commitment [RNA-seq] 15.99
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 15.82
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 15.7
The cohesin complex prevents Myc-induced replication stress 15.49
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 15.05
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 14.89
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 14.81
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.27
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.27
p53 activity results in DNA replication fork processivity 13.95
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 13.93
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 13.48
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  13.48
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 13.28
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 13.28
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 13.13
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 13.13
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 13.05
Androgen Receptor-regulated genes in prostate cancer cells 13.05
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 13.04
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 12.49
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 12.31
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 12.31
RNA splicing alteration on glioblastoma and normal neural stem cells 12.09
RNA-seq of cells with TET1 knockout 11.96
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 11.77
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 11.73
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 11.71
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 11.62
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 11.61
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 11.33
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 11.33
Differential gene expression of human melanoma cells [RNA-seq] 11.26
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 11.26
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 11.05
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 10.92
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 10.84
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 10.82
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 10.82
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 10.74
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 10.74
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 10.67
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 10.57
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 10.41
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 10.31
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 10.12
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 10.12
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 10.1
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 10.1
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 10.05
Epigenome regulation during epidermal lineage commitment 9.55
Transcriptional effect of ETV1 knockdown in melanoma cells 9.55
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 9.09
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 9.05
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 9.05
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 9.01
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.59
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.59
IRF2 is a master regulator of human keratinocyte stem cell fate 8.5
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 8.5
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 8.45
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 8.44
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 8.28
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 8.15
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 8.03
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 8.0
circRNA profile in hypopharyngeal cancer 7.9
Transcriptome of human white and brown adipose tissue biopsies 7.89
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 7.88
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 7.78
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 7.6
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 7.53
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 7.37
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 7.22
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 7.14
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 7.13
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 7.03
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 6.96
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 6.96
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 6.95
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 6.68
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 6.64
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 6.45
GATA3-mediated chromatin reprogramming in breast cancer cells 6.4
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 6.39
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 6.37
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 6.31
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 6.29
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 6.28
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 6.22
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 6.08
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 5.9
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 5.65
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 5.65
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 5.64
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 5.63
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 5.62
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 5.6
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 5.55
Expression patterns in chronic thromboembolic pulmonary hypertension 5.46
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.28
Hepatosplenic T cell lymphoma 5.28
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 5.16
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.09
Ebola virus (EBOV) infection of ARPE-19 cells 5.05
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 5.05
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 5.04
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 5.02
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.99
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.97
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 4.89
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 4.87
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.85
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 4.71
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 4.69
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 4.69
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 4.69
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 4.65
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 4.65
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 4.61
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.47
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 4.43
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 4.36
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 4.36
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.31
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.27
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 4.26
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 4.25
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.22
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.22
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 4.22
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 4.18
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 4.13
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 4.12
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 4.12
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 4.08
Gene expression of thyroid cancer cell lines 4.07
KLF6-dependent transcription in renal cancer cells 4.06
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 4.03
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 4.02
An acquired vulnerability of drug resistant melanoma with therapeutic potential 4.02
Spliceosomal disruption of the non-canonical BAF complex in cancer 4.0
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.98
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 3.89
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 3.88
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.85
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 3.81
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 3.81
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 3.73
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 3.73
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 3.72
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.69
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 3.68
p63 controls the enhancer landscape during keratinocyte differentiation 3.67
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 3.65
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.62
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 3.59
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.53
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.48
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.48
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.48
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.47
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 3.36
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 3.36
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 3.33
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 3.33
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 3.33
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 3.3
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 3.3
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 3.26
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 3.26
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.25
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 3.21
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.17
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.16
Random mono-allelic expression in MECP2-mutated cells 3.14
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 3.11
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 3.08
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 3.07
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 3.02
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.01
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.01
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.95
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.95
Global epigenomic reconfiguration during mammalian brain development 2.95
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 2.92
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 2.91
Nucleoporin-mediated regulation of cell identity genes 2.9
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.87
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.87
Functional astrocytes differentiated from hiPSCs 2.86
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.78
Transcriptomic analysis of LSD1 2.76
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.75
Gene expression changes upon drug withdrawal (Mel888 cell line) 2.68
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 2.67
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.61
Transcriptome of U251 cells overexpression complement component 7 2.6
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 2.6
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 2.57
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.55
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 2.55
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.54
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.54
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.5
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.48
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 2.47
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.39
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.39
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.37
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.37
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.37
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 2.37
RNA sequencing of human pancreatic cancer cell lines 2.29
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.29
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 2.29
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 2.28
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.26
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.22
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 2.17
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 2.17
Toxoplasma gondii infection of human retinal pigment epithelial cells 2.16
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 2.16
ML29755 RNA-seq data 2.14
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 2.14
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.14
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.09
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 2.08
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 2.06
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 2.02
Transcriptional responses of melanoma cells to BRAF inhibition 2.01
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 2.01
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 2.01
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.0
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.0
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.0
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.0
RNA-sequencing of healthy human skeletal myocytes 1.98
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.98
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.97
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.95
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.95
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.92
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.92
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.91
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.91
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.91
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.9
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.87
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 1.86
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.84
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 1.84
RNA sequencing of mechanically strained NHEKs and control NHEKs 1.82
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.79
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 1.75
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.74
Patient-derived xenograft platform for metastatic melanoma 1.73
RNA-seq in transgenic cells 1.7
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.69
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.69
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 1.69
Gene expression profile in breast cancer cell lines using RNA sequencing 1.68
A sister of NANOG regulates genes expressed in pre-implantation human development 1.67
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 1.66
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.64
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 1.62
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 1.62
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 1.54
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.52
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.52
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.5
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.5
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 1.49
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.46
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.45
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.44
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 1.37
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.34
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 1.33
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.33
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 1.29
RNAseq of IL-36 stimulated primary human keratinocytes 1.29
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 1.28
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.26
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 1.26
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 1.26
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 1.25
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.23
RNA-seq melanoma 1.23
Gene expression analysis of human liver progenitor-like cells in culture 1.15
6mer seed toxicity in tumour suppressive microRNAs 1.14
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.13
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.12
CDK12 mediated transcriptional regulation in U2OS cells 1.02
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.02
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 1.01
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.0
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 0.98
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.98
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.98
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.97
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.97
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.97
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.96
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 0.94
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.94
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.93
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.93
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.92
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.92
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.92
Ribosomal protein RPL26 is the principal target of UFMylation 0.9
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.89
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.87
Gene expression analysis upon mtDNA depletion 0.87
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.85
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.85
BMS-470539 on human synovial fibroblasts 0.83
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 0.83
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.83
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 0.82
Identification of long noncoding RNAs regulated by p53 0.8
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 0.79
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.79
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 0.76
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.74
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.74
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 0.73
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 0.67
RNA-seq of cancer cell lines treated with T-025 0.67
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.66
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 0.65
Transcriptome analyses of human pancreatic islets and pseudoislets 0.64
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.62
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.62
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.6
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.6
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.59
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.57
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.57
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.55
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.55
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.55
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 0.55
Analysis of transcriptional regulation by Myt1 and Myt1l 0.54
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.5
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.49
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 0.49
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.49
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.46
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.46
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.46
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.43
Role of COP1 on MAP kinase transcriptional output in melanoma 0.42
RNAseq analysis of ruxolitinib treated breast cancers 0.41
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 0.4
Fibroblasts in cholesteatoma activate osteoclasts. 0.39
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.38
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.36
PRDM1 inhibits proliferation of human colon cancer organoids 0.36
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.33
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.32
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.32
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.3
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.3
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.3
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.3
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.3
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.29
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.29
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.27
RNA-seq analysis of control and Myc-induced U2OS cells 0.25
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.24
RNA-seq in endometrial stromal tumors 0.22
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.22
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.22
Ribosome profiling upon inhibition of eIF4A 0.2
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 0.18
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.18
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 0.18
Activity-dependent transcriptional changes in human neurons 0.18
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.17
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.17
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.17
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.15
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.15
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.14
Gene expression analysis of breast cancer cell-lines 0.14
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.14
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.14
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 0.12
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.12
Human ovarian granulosa cell transcriptome 0.11
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.1
Identification of expressed and conserved human non-coding RNAs 0.09
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.09
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.09
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.07
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.07
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.04
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation